Louis Yu
Corporate Officer/Principal chez BAUSCH HEALTH COMPANIES INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| John Paulson | M | 68 | 7 ans | |
| Robert Power | M | 67 | 16 ans | |
| Thomas Appio | M | 61 | - | |
| Seana-Lyn Carson | F | 51 | 15 ans | |
| Richard Mulligan | M | 69 | 2 ans | |
| John Barresi | M | 51 | 2 ans | |
| Jeff Hartness | M | - | - | |
| Christina Ackermann | F | 59 | 8 ans | |
| Amy Wechsler | M | 54 | 8 ans | |
| Brett Icahn | M | 44 | 3 ans | |
| Sarah Kavanagh | F | 67 | 8 ans | |
| Steven Miller | M | 35 | 3 ans | |
| Thomas Ross | M | 73 | 8 ans | |
| Donal O'Connor | M | 73 | 10 ans | |
| Russel Robertson | M | 76 | 8 ans | |
| Arthur J. Shannon | M | - | 7 ans | |
| Grainne Quinn | M | 54 | 10 ans | |
| Robert Willis | M | 55 | 11 ans | |
| Tage Ramakrishna | M | 49 | 13 ans | |
| William Norman Woodfield | M | 48 | - | |
| Dennis Asharin | M | - | 17 ans | |
| Glenn Wright | M | - |
Product Quality Research Institute
| 3 ans |
| Alison Ives | F | - | 9 ans | |
| Mirza Dautbegovic | M | - | - | |
| Kathleen Fitzpatrick | F | - | 5 ans | |
| Kevin Wiggins | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| John Hendrickson | M | 61 | 11 ans | |
| Robert Alexander Ingram | M | 81 | 14 ans | |
| Robert L. Rosiello | M | 66 | 1 ans | |
| Joseph Papa | M | 68 | 6 ans | |
| Andrew von Eschenbach | M | 82 | 4 ans | |
| Kevin Walsh | M | - | - | |
| Ran Gottfried | M | 79 | - | |
| Laurence J. Downey | M | - |
Solvay Pharmaceuticals, Inc.
 Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | 9 ans |
| Shlomo Yanai | M | 71 | 2 ans | |
| Ellen R. Hoffing | F | 66 | 9 ans | |
| Scott Andrew Hirsch | M | 47 | 5 ans | |
| Ronald L. Winowiecki | M | 58 | 11 ans | |
| Tom Vadaketh | M | 61 | 1 ans | |
| Eric Abramson | M | - | - | |
| Frank Perier | M | 64 | 10 ans | |
| Christopher Chai | M | 58 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 ans |
| Anne Michelle Whitaker | F | 56 | 2 ans | |
| Robert Hale | M | 39 | 6 ans | |
| Argeris Karabelas | M | 71 | 7 ans | |
| Jacqualyn Fouse | M | 62 | - | |
| William Ackman | M | 57 | 1 ans | |
| Ben-Zion Zilberfarb | M | 74 | - | |
| David T. Gibbons | M | 80 | - | |
| Fred Eshelman | M | 76 | 3 ans | |
| Richard de Schutter | M | 83 | 6 ans | |
| Sam Eldessouky | M | 51 | 6 ans | |
| Marc. A. A. A. L Coucke | M | 59 | 1 ans | |
| Solomon David | M | 57 | 12 ans | |
| Susan Abushakra | M | 63 | - | |
| Robert Spurr | M | 62 | - | |
| Thomas Nee | M | - | 9 ans | |
| Marc Paradis | M | - | 1 ans | |
| Karin Walker | F | 60 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 ans |
| Chris Roop | M | - | 2 ans | |
| Conor Walsh | M | 51 | - | |
| Steve Laninga | M | - | 7 ans | |
| Louis K. Cherico | M | 53 | - | |
| Thomas A. Hart | M | 68 | 5 ans | |
| Richard Lajoie | M | - | - | |
| Rona Caswell | F | - | - | |
| Scott Horton | M | 60 | 1 ans | |
| Michael McMyne | M | - | 1 ans | |
| Christopher J. Eppel | M | 58 | 7 ans | |
| Stacey Williams | F | - | 5 ans | |
| Lainie Keller | F | - | - | |
| Jeff Jonas | M | 71 | 5 ans | |
| James Herman | M | 67 |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | 5 ans |
| Frank Truslow | M | - | 5 ans | |
| William Humphries | M | 57 | 3 ans | |
| K. Barnette | M | 56 |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | 3 ans |
| Stephen E. King | M | 59 | - | |
| Sharon Kochan | F | 55 | - | |
| Jeffrey Needham | M | 68 | 11 ans | |
| Jatin Shah | M | 70 | 12 ans | |
| Cheryl L. Cohen | F | 58 |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | 6 ans |
| Ari Kellen | M | - | 2 ans | |
| John Groom George | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Joseph M. Davie | M | 84 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 ans |
| Paul Herendeen | M | 68 | 5 ans | |
| Paul J. Frohna | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 2 ans |
| Michael E. Faerm | M | 57 | 2 ans | |
| Charles Ryan | M | 60 | 11 ans | |
| Benedict Osorio | M | 67 | 4 ans | |
| Irina R. Koffler | F | - | 5 ans | |
| Scott Jamison | M | 67 | - | |
| Bruce Philip Pritchard | M | 51 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 2 ans |
| Philip Wells | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 ans |
| Hsiao Lieu | M | 53 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 ans |
| Eugene Gong | M | - | 7 ans | |
| Eric Brad Rabinowitz | M | 48 | - | |
| Robert Jackson | M | - | 14 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Suisse | 45 | 46,39% |
| Etats-Unis | 27 | 27,84% |
| Irlande | 25 | 25,77% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
